You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JI-101

Showing 1 - 25 of 1,045
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Body Weight, Body Fat, Overweight Trial (Vigiis 101 Lactobacillus Capsules, Placebo Capsules)

Not yet recruiting
  • Body Weight
  • +2 more
  • Vigiis 101 Lactobacillus Capsules
  • Placebo Capsules
  • (no location specified)
May 18, 2023

Presbyopia, Near Vision, Miosis Trial in China (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic

Not yet recruiting
  • Presbyopia
  • +3 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Wenzhou, Zhejiang, China
  • +18 more
Sep 19, 2023

Mild Cognitive Impairment, Accidental Falls, Aging Trial (dual-task tai ji quan, standard tai ji quan, stretching)

Not yet recruiting
  • Mild Cognitive Impairment
  • +2 more
  • dual-task tai ji quan
  • +2 more
  • (no location specified)
Feb 13, 2023

Mild Cognitive Impairment Trial in Eugene (tai ji quan, Stretching)

Completed
  • Mild Cognitive Impairment
  • tai ji quan
  • Stretching
  • Eugene, Oregon
    Oregon Research Institute
Dec 1, 2022

Moderate or Severe Submental Fullness Trial in Seongnam, Seoul (Polyene phosphatidylcholine injection, Placebo)

Recruiting
  • Moderate or Severe Submental Fullness
  • Polyene phosphatidylcholine injection
  • Placebo
  • Seongnam, Gyeonggi, Korea, Republic of
  • +3 more
Aug 27, 2021

Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

Not yet recruiting
  • Chronic Hepatitis b
  • Auckland, New Zealand
    New Zealand Clinical Research Auckland
Jul 26, 2023

Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • KSD-101
  • Wuhan, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023

Low Back Pain Trial in New York (T'ai Chi and Qigong Rehabilitation, Usual care)

Recruiting
  • Low Back Pain
  • T'ai Chi and Qigong Rehabilitation
  • Usual care
  • New York, New York
    New York Presbytarian Hospital
Mar 1, 2023

Solid Tumor Trial in China (BPB-101)

Not yet recruiting
  • Solid Tumor
  • Guangzhou, Guangdong, China
  • +3 more
May 11, 2023

Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)

Recruiting
  • Frontotemporal Dementia
  • +3 more
  • Intrathalamic AAV.PGRN administration
  • Intrathalamic AVB-101
  • Katowice, Poland
  • +3 more
Oct 6, 2023

Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Recruiting
  • Lung Cancer
    • Shanghai, China
      Shanghai Chest Hospital
    Jul 20, 2023

    Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

    Completed
    • Nonalcoholic Fatty Liver Disease
    • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
    • +3 more
    • Jerusalem, Israel
      Hadassah University Hospital - Ein Kerem
    Sep 13, 2023

    Cancer Trial (Antibody-Drug Conjugate)

    Not yet recruiting
    • Cancer
    • Antibody-Drug Conjugate
    • (no location specified)
    Aug 23, 2023

    Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)

    Recruiting
    • Community-acquired Pneumonia
    • Bacterial Pneumonia
    • Cincinnati, Ohio
      Medpace Clinical Pharmacology Unit
    Jan 20, 2023

    Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,

    Not yet recruiting
    • Idiopathic Inflammatory Myopathies
    • +3 more
    • (no location specified)
    Nov 21, 2023

    NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)

    Not yet recruiting
    • NSCLC
    • +5 more
    • (no location specified)
    Jun 1, 2023

    Orthostatic Hypotension Trial in Newcastle Upon Tyne (ISO-101)

    Not yet recruiting
    • Orthostatic Hypotension
    • ISO-101
    • Newcastle Upon Tyne, United Kingdom
      Falls and Syncope Service, Older People's Medicine, The Newcastl
    Sep 8, 2023

    Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

    Not yet recruiting
    • Epidermolysis Bullosa
    • +2 more
    • EB-101 Surgical application of RDEB wounds
    • Redwood City, California
    • +1 more
    Feb 13, 2023

    Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)

    Not yet recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
    • Hefei, Anhui, China
    • +7 more
    Jun 27, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Atezolizumab
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 6, 2023

    Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

    Recruiting
    • Age-Related Macular Degeneration
    • VOY-101
    • Sydney, New South Wales, Australia
    • +3 more
    Oct 17, 2023

    Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

    Recruiting
    • Oropharyngeal Squamous Cell Carcinoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 22, 2022

    Pulmonary Arterial Hypertension Trial in Indianapolis (AV-101)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Indianapolis, Indiana
      Indiana University Health
    Dec 6, 2022

    Belatacept to Delay Tacrolimus Initiation in Kidney Transplant

    Active, not recruiting
    • Belatacept Impact on Patients With GDF
    • impact of administering one dose of belatacept on eGFR
    • Dallas, Texas
      Methodist Dallas Medical Center
    Oct 17, 2023

    HIV-1-infection Trial in San Francisco, Saint Louis, Camden (EBT-101)

    Enrolling by invitation
    • HIV-1-infection
    • EBT-101
    • San Francisco, California
    • +2 more
    Oct 17, 2022